Added to YB: 2025-07-02
Pitch date: 2025-07-01
CLPT [bullish]
ClearPoint Neuro, Inc.
-16.7%
current return
Author Info
MVC Investing is a long-term investor. BSc in Economics, MSc in Finance. Equity Analyst with a focus on Fundamental Analysis and Valuation. Sign up for the newsletter.
Company Info
ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States.
Market Cap
$272.3M
Pitch Price
$11.26
Price Target
N/A
Dividend
N/A
EV/EBITDA
-14.10
P/E
-10.18
EV/Sales
7.70
Sector
Health Care Equipment and Supplies
Category
growth
Portfolio Update – 06/30/2025 – H1 Review - ClearPoint Neuro, Inc.
CLPT new position: Building position (avg $12.70/share) as platform becomes critical for neurological drug delivery. Asymmetric upside not dependent on single FDA approval. Key catalyst: QURE's AMT-130 data using CLPT platform. Multi-year hold through expected volatility. Market underappreciating long-term potential.
Read full article (1 min)